Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
This study is currently recruiting participants.
Verified July 2012 by National Cancer Institute (NCI)
Study NCT00716976
Information provided by National Cancer Institute (NCI)
First Received on July 15, 2008.
Last Updated on July 12, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
